PainWeek 2016

PainWeek 2016

DAY 3
Key Considerations for Providing Naloxone
The opioid overdose death toll has been steadily increasing for more than a decade, making it a leading cause of accidental death in the United States.
Potential Adverse Effects Associated with Naloxone
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses potential adverse effects associated with naloxone.
Tips for Assessing Patients' Risk of Opioid Overdose
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses how health-system pharmacists can assess patients' risk for opioid overdose.
Administration Counseling Tips for Naloxone
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses what pharmacists should tell patients about administering naloxone.
Key Stakeholders Needed in the Development of Outpatient Naloxone Policies
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.
How Can Health-System Pharmacists Work with Community Pharmacists to Orient Staff on Naloxone Use?
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses how health-system and community pharmacists can work together to provide naloxone.
How Expensive is Naloxone for Patients?
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses prices of naloxone products.
DAY 2
4 Things Pharmacists Should Know About Opioid-Induced Constipation
Although it's difficult to determine exactly how many patients experience opioid-induced constipation, the large quantities of prescribed opioids in circulation create widespread potential for this bothersome adverse effect.
How Pharmacists Can Help Prevent OIC
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses how pharmacists can help prevent OIC.
Counseling Points for OIC Patients
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses counseling points for OIC patients.
Steps Pharmacists Should Take to Reduce OIC
Jeffrey Gudin, MD, outlines the steps pharmacists should take to reduce opioid-induced constipation.
Latest Advancements in OIC Treatment
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses the latest advancements in OIC treatment.
How Pharmacy-Based OIC Care Differs from Other Settings
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses how pharmacy-based OIC care differs from other settings.
OTC Recommendations for OIC Symptoms
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses OTC recommendations for OIC symptoms.
How Often Pharmacists Work with OIC Patients
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses how often pharmacists work with OIC patients.
The Impact of OIC on Patients Taking Opioids
Jeffrey Gudin, MD, describes the impact of opioid-induced constipation on patients taking opioids.
Where Does Fiber Supplementation Fit into OIC Care?
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses where fiber supplementation fits into OIC care.
DAY 1
7 Myths About Opioids with Abuse-Deterrent Properties
There are many misconceptions surrounding pain management, especially when it comes to opioids with abuse-deterrent properties.
How Can You Tell Whether an Opioid Is Abuse-Deterrent?
J. David Haddox, DDS, MD, describes how clinicians can determine whether an opioid has abuse-deterrent properties.
The Pharmacist's Role in Deterring Opioid Abuse
J. David Haddox, DDS, MD, describes the pharmacist's role in deterring opioid abuse.
Myth or Fact: Opioid Abuse Is an Epidemic
The answer may surprise you.
The Most Common Method of Opioid Abuse
J. David Haddox, DDS, MD, describes the most common method of opioid abuse.
How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?
J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.
How Most Nonmedical Opioid Users Obtain the Drug
J. David Haddox, DDS, MD, explains how most nonmedical opioid users obtain the drug.
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.